FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) FF305 確認 根據《主板上市規則》第13.25C條 / 《GEM上市規則》第17.27C條，我們在此確認，據我們所知所信，第一章節所述的每項股份發行或庫存股份出售或轉讓已獲發行人董事會正式授權批准，並遵 照所有適用上市規則、法律及其他監管規定進行，並在適用的情況下： (註7) (i) 上市發行人已收取其在是次股份發行或庫存股份出售或轉讓應得的全部款項； (viii) 有關債券、借貸股份、票據或公司債券的信託契約/平邊契據經已製備及簽署，有關詳情已送呈公司註冊處處長存檔（如法律如此規定）。 表格類別： 股票 狀態： 新提交 公司名稱： 石四藥集團有限公司 呈交日期： 2026年1月9日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | ...

Core Viewpoint - The company, Stone Four Pharmaceutical Group, has been actively repurchasing its shares, indicating a potential confidence in its stock value and future performance [2] Summary by Category Share Buyback Activity - On January 8, the company repurchased 1.486 million shares at a price range of HKD 3.030 to HKD 3.050, totaling HKD 4.5217 million [2] - The stock closed at HKD 3.050 on the same day, reflecting a 0.99% increase, with a total trading volume of HKD 20.5504 million [2] - Since January 5, the company has conducted share buybacks for four consecutive days, accumulating a total of 5.214 million shares repurchased, with a total expenditure of HKD 15.585 million [2] - During this period, the stock price has increased by 6.64% [2] Buyback Details - The detailed buyback information is as follows: - January 8: 1.486 million shares at a maximum price of HKD 3.050 and a minimum price of HKD 3.030, totaling HKD 4.5217 million [2] - January 7: 1.128 million shares at a maximum price of HKD 3.030 and a minimum price of HKD 3.010, totaling HKD 3.4063 million [2] - January 6: 1.500 million shares at a maximum price of HKD 3.000 and a minimum price of HKD 2.960, totaling HKD 4.4694 million [2] - January 5: 1.100 million shares at a maximum price of HKD 2.920 and a minimum price of HKD 2.890, totaling HKD 3.1876 million [2]

Core Viewpoint - The company, 石四药集团, announced a share buyback plan, indicating confidence in its stock value and future prospects [1] Group 1: Share Buyback Details - The company will repurchase 1.486 million shares at a total cost of HKD 4.5217 million [1] - The buyback price per share ranges from HKD 3.03 to HKD 3.05 [1]

格隆汇1月8日丨石四药集团(02005.HK)发布公告，2026年1月8日耗资452.17万港元回购148.6万股，回购 价格每股3.03-3.05港元。 ...

Core Viewpoint - The company, Stone Four Pharmaceutical Group, announced a share buyback plan, indicating confidence in its stock value and future prospects [1] Group 1: Share Buyback Details - The company will spend HKD 4.5217 million to repurchase 1.486 million shares [1] - The buyback price per share ranges from HKD 3.03 to HKD 3.05 [1]

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 石四藥集團有限公司 呈交日期： 2026年1月8日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 02005 | 說明 | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | | 庫存股份變動 | | | | | 事件 | 已發行股份（不包括庫存股份）數 目 | | 佔有關事件 ...

Core Viewpoint - The latest shareholder equity disclosures for Baixinan-B (02185), Tongjing New Energy (08326), and Shisi Pharmaceutical Group (02005) were conducted on January 8, 2026, revealing changes in shareholdings among key institutional investors [1]. Group 1: Baixinan-B (02185) - Wang Philip Li increased his holdings from 85.2477 million shares to 85.2577 million shares, maintaining a holding percentage of 36.17% [2]. - Winning Powerful Limited also slightly increased its holdings from 46.0656 million shares to 46.0756 million shares, with a holding percentage of 19.55% [2]. Group 2: Tongjing New Energy (08326) - Well Mount Holdings Limited raised its holdings from 97.975 million shares to 101 million shares, increasing its holding percentage from 7.98% to 8.22% [2]. Group 3: Shisi Pharmaceutical Group (02005) - Qu Jiguang increased his holdings from 1.23 billion shares to 1.231 billion shares, with a holding percentage rising from 41.68% to 41.72% [2].

石四药集团回购明细 | 日期 | 回购股数（万股） | 回购最高价（港元） | 回购最低价（港元） | 回购金额（万港元） | | --- | --- | --- | --- | --- | | 2026.01.07 | 112.80 | 3.030 | 3.010 | 340.63 | | 2026.01.06 | 150.00 | 3.000 | 2.960 | 446.94 | | 2026.01.05 | 110.00 | 2.920 | 2.890 | 318.76 | （文章来源：证券时报网） 证券时报·数据宝统计，石四药集团在港交所公告显示，1月7日以每股3.010港元至3.030港元的价格回购 112.80万股，回购金额达340.63万港元。该股当日收盘价3.020港元，上涨0.67%，全天成交额1323.39万 港元。 自1月5日以来公司已连续3日进行回购，合计回购372.80万股，累计回购金额1106.34万港元。 其间该股 累计上涨5.59%。（数据宝） ...

相关事件 石四药集团(02005.HK)1月7日耗资340.63万港元回购112.8万股 石四药集团(02005.HK)1月6日耗资446.94 万港元回购150万股 格隆汇1月7日丨石四药集团(02005.HK)发布公告，2026年1月7日耗资340.63万港元回购112.8万股，回购 价格每股3.01-3.03港元。 ...

智通财经APP讯，石四药集团(02005)发布公告，于2026年1月7日，该公司斥资340.63万港元回购112.8万 股股份，每股回购价3.01-3.03港元。 ...